References
- Wadler S, Schwartz E L, Goldman M., et al. Preclinical and clinical studies of 5-fluorouiacil (FURA and recombinant alpha-2a-interferon (IFN) against gastric (GI) malignancy. Clin Res 1988; 36: 5
- Wadler S, Schwartz E L, Werso R. D., et al. 5-Fluorouracil and recombinant alpha-2a-interferon: a rationally designed regimen against advanced colorectal carcinoma. I Clin Oncol, (submitted)